Please login to the form below

Not currently logged in
Email:
Password:

Jörg Reinhardt - new CEO Bayer Healthcare

Bayer has announced that Dr Jörg Reinhardt, former chief operating officer of Novartis, is to replace Arthur Higgins as Bayer Healthcare CEO

Dr Jörg Reinhardt, former chief operating officer of Novartis, has been appointed chairman of the board of management of Bayer Healthcare and chairman of the Bayer Healthcare executive committee with effect from August 15, 2010. 

Commenting on the new appointment, Werner Wenning, chairman of the board of management of Bayer AG said: "Dr Reinhardt is an acknowledged expert with many years of experience in the healthcare industry."

"We are convinced of his ability to provide a decisive impetus to our global healthcare business and further expand our strong competitive positions," he continued.

Martin J Higgins and Dr Jörg Reinhardt, Bayer Healthcare  

Outgoing CEO Arthur J Higgins (left) and Dr Jörg Reinhardt 

Current healthcare CEO, Arthur J Higgins, will leave the company on April 30 at his own request.

Dr Marijn Dekkers, member of the Bayer AG board of management and its designated chairman, will take over as head of Bayer Healthcare on a temporary basis from May 1, 2010 until Dr Reinhardt's appointment takes effect.

21st April 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Apex.co.uk Conferences, Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading event and exhibition agencies, specialising in healthcare. We understand your communication goals, whether...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics